We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App

Plant Cellulose Considered As Bone Implant Material

By HospiMedica International staff writers
Posted on 03 Apr 2019
Print article
Image: A new study claims nanocrystals derived from plant cellulose can form a strong but lightweight aerogel (Photo courtesy of Clare Kiernan/ UBC).
Image: A new study claims nanocrystals derived from plant cellulose can form a strong but lightweight aerogel (Photo courtesy of Clare Kiernan/ UBC).
A nanocrystal aerogel formed from plant cellulose could provide the scaffolding required for the growth of new bone, claims a new study.

Developed by researchers at the University of British Columbia (UBC; Vancouver, Canada) and McMaster University (Hamilton, ON, Canada), the biologic aerogel material is made from chemically cross-linked cellulose nanocrystals (CNC), and is designed to support osteoblast proliferation and enhance bone regeneration. The highly porous CNC aerogels also promote and support the growth of hydroxyapatite on their surface, as was demonstrated when submerged in simulated body fluid solutions.

In an in-vivo study of the CNC aerogels, which were implanted into the calvarian bone of adult male Long Evans rats, their osteconductive properties were demonstrated, and an increase in bone volume of up to 50% was shown, as compared to sham sites. And at 3- and 12-week time points, the CNC aerogels showed an increased bone volume fraction of 33% and 50%, respectively. The study was published on March 15, 2019, in Acta Biomaterialia.

“We can see this aerogel being used for a number of applications, including dental implants and spinal and joint replacement surgeries, and it will be economical because the raw material, the nanocellulose, is already being produced in commercial quantities,” said senior author biomedical engineer Professor Kathryn Grandfield, PhD, of McMaster University. “This summer, we will study the mechanisms between the bone and implant that lead to bone growth. We'll also look at how the implant degrades using advanced microscopes.”

“Most bone graft or implants are made of hard, brittle ceramic that doesn't always conform to the shape of the hole, and those gaps can lead to poor growth of the bone and implant failure,” said lead author Daniel Osorio, MSc, a PhD student in chemical engineering at McMaster University. “We created this cellulose nanocrystal aerogel as a more effective alternative to these synthetic materials.”

Cellulose is a homopolysaccharide of glucopyranose that can be either regenerated to form organized fibers or remain non-regenerated with unorganized fibers. Structurally, cellulose consists of crystalline and amorphous regions; by treating it with strong acid, the amorphous regions can be broken up to produce CNC. Cellulose is an important structural component of the primary cell wall of green plants, and is the most abundant organic polymer on Earth. The cellulose content of cotton fiber is 90%, and of wood 40–50%.

Related Links:
University of British Columbia
McMaster University

Gold Member
Solid State Kv/Dose Multi-Sensor
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
Vital Signs Monitor
Aurus 10

Print article


Critical Care

view channel
Image: This study is significant as it addresses a treatment approach that has not been extensively studied before (Photo courtesy of 123RF)

Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease

There has been a lack of extensive research on the use of drug-coated balloon (DCB)-only strategy for the treatment of de novo left main coronary artery disease, especially in high bleeding risk (HBR) patients.... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.